Press releases in 2024

11. 10. 2024 |
Lek, a Sandoz company, held the 20th annual Diseases of Our Time meeting, which has been bringing together the most prominent experts in the field of medicine and pharmacy for ...
27. 9. 2024 |
Lek, a Sandoz Group company, received the Include.All award at a ceremony during the Management Congress, awarded by the Female Managers' Section of the Managers' Association of Slovenia in recognition ...
20. 9. 2024 |
The Slovenian Chemistry Days 2024 event took place from 18 to 20 September at the congress center of Grand Hotel Bernardin in Portorož. This  year, for the first time at ...
17. 9. 2024 |
The second ScienceBEAT, organised by Lek for promising Slovenian and foreign young experts took place between 11 and 13 September in Ljubljana, Maribor, and Lendava, and has successfully concluded. It ...
12. 9. 2024 |
Lek, a Sandoz company, has signed a strategic cooperation agreement with representatives of the University of Ljubljana, the University of Maribor, and the University of Primorska, which will further strengthen ...
11. 9. 2024 |
Yesterday, as part of Innovation Day, the Chamber of Commerce and Industry of Slovenia presented the 22nd national awards for the best innovations. At the awards ceremony, which took place ...
3. 9. 2024 |
On August 30, the Lek d.d. General Meeting confirmed the decision to change the corporate governance system, as mandated by the company’s sole shareholder, Sandoz AG. The decision concerns the ...
22. 8. 2024 |
Lek, as part of Sandoz, the global leader in generic and biosimilar medicines, launches a new ustekinumab biosimilar intended to treat patients with chronic inflammatory diseases in Slovenia. The medicine ...
20. 6. 2024 |
Lek, a Sandoz company, is the recipient of the 2024 Engineering Spark award for its TechBEAT event. The award, presented by the “We Will Be Engineers!” initiative, recognizes groundbreaking practices ...
12. 6. 2024 |
Lek, a Sandoz company, symbolically raised the rainbow flag in front of its Ljubljana office building and at its Lendava site as a sign of support for the LGBTQI+ community.
31. 5. 2024 |
Lek remains committed to supporting education and scientific research. They believe that science should be accessible to everyone, so they strive to bring science closer to young children through various ...
21. 5. 2024 |
Asist. Prof. Samo Rožman, PhD, Global  Medical Development Manager from Sandoz Development Center Slovenia, is this year's recipient of the prestigious Minařik Award, the highest award of the Slovenian Pharmaceutical ...
15. 5. 2024 |
Lek, a Sandoz company, was awarded the  "Family Friendly Company" certificate by the Institute for Labor and  the Ministry of Labor. This is an acknowledgement of Lek's commitment to  improving ...
14. 5. 2024 |
From May 9 to 10, Lek hosted TechBEAT, offering promising secondary school students from Slovenia a unique insight into the challenges and trends in the pharmaceutical industry, an opportunity to ...
19. 4. 2024 |
Today, Sandoz celebrated the start of construction of its state-of-the-art Biosimilars Development Center inLjubljana. Dignitaries including Prime Minister Dr Robert Golob, complimented Sandoz's commitment to innovation and enabling access to affordable ...
4. 4. 2024 |
Lek, a Sandoz company, has been awarded the title of Most Reputable Employer 2023, presented by the job portal Mojedelo.com since 2007.
29. 3. 2024 |
Lek, a Sandoz company, won the Golden Practice Award at yesterday's Golden Thread Awards ceremony, presented by the Dnevnik daily for innovative  and efficient HR practices. The award was won ...
29. 1. 2024 |
The 16th consecutive international Responsible Care® certificate confirms that Lek is successfully upgrading its environmentally responsible business operations and, in doing so, remains committed to exceeding the standards.
18. 1. 2024 |
Lek, a Sandoz company, has obtained the prestigious international certificate "Top Employer" for being the best employer at the Slovenian level. The title "Top Employer 2024" confirms its long-standing commitment ...